SCHEMBL3846231

SCHEMBL3846231

CN1CCN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4C(F)(F)F)cc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 10/20 0.46
ALDH1A1 P00352 5/20 0.45
CYP1A2 P05177 5/20 0.45
CYP3A4 P08684 5/20 0.45
TSHR P16473 4/20 0.45
HIF1A Q16665 4/20 0.45
USP2 O75604 3/20 0.45
MAPK1 P28482 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C19 P33261 3/20 0.45
MET P08581 2/20 0.39
LMNA P02545 3/20 0.39
CLK4 Q9HAZ1 2/20 0.39
ADRB2 P07550 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850354 0.89 NCF1 (0.48) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3847491 0.89 CYP2C19 (0.45) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3848852 0.88 ALDH1A1 (0.43) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3848728 0.87 CHRM4 (0.39) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3850111 0.87 MTOR (0.39) MAPKAPK2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL3845802 0.87 CTSS (0.37) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3846799 0.86 MTOR (0.40) ALDH1A1CYP3A4MAPK1KDM4EHPGD
SCHEMBL3847422 0.86 MAPKAPK2 (0.42) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3848141 0.85 CYP3A4 (0.50) ALDH1A1CYP1A2CYP3A4TSHRCLK4
SCHEMBL3849050 0.84 AKR1C3 (0.43) ALDH1A1CYP1A2CYP3A4TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed